Physician profile
David Goodman
NPI 1700284221
$2,520.73
in general payments reported to CMS, 2019-2025
11 companies · $405 in 2025
The $405 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $482 · 2022: $318 · 2023: $809 · 2024: $506 · 2025: $405.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,145 · Travel and Lodging: $576.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,144.75 |
| Travel and Lodging | $575.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,447.09 | 2022-2025 | Prostep, Citrefix, Augment Injectable |
| Cgg Medical INC | $482.46 | 2020 | |
| Next Science LLC | $135.52 | 2022 | |
| Supreme Orthopedic Systems, LLC | $131.22 | 2024 | |
| Abbott Laboratories | $107.71 | 2025 | Esprit |
| Native Surgical, LLC | $62.08 | 2025 | |
| Smith+Nephew, INC. | $53.33 | 2023 | Evos |
| Paragon 28, INC. | $44.31 | 2023 | Portfolio |
| Pacira Pharmaceuticals Incorporated | $22.32 | 2025 | Iovera, Exparel |
| Tactile Systems Technology INC | $19.28 | 2025 | Nimbl, Flexitouch Plus |
| Curonix LLC | $15.41 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Goodman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.